Loading...

Jeremy Sharib, MD

Title(s)Affiliate, Surgery
SchoolSchool of Medicine
Address600 16th St
San Francisco CA 94158
Phone415-476-1239
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cost-effectiveness of consensus guideline-based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery. 2020 Jul 29. Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EM. PMID: 32739138.
      View in: PubMed   Mentions:    Fields:    
    2. Randomized Clinical Trial of Nasogastric Tube Placement After Pancreaticoduodenectomy. JAMA Surg. 2020 Jul 15; e202305. Sharib JM, Nakakura EK. PMID: 32667647.
      View in: PubMed   Mentions:    Fields:    
    3. Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer. Clin Cancer Res. 2020 Jul 15; 26(14):3608-3615. Moroz A, Wang YH, Sharib JM, Wei J, Zhao N, Huang Y, Chen Z, Martinko AJ, Zhuo J, Lim SA, Zhang LH, Seo Y, Carlin S, Leung KK, Collisson EA, Kirkwood KS, Wells JA, Evans MJ. PMID: 32341034.
      View in: PubMed   Mentions:    Fields:    
    4. The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts. Biol Chem. 2019 11 26; 400(12):1629-1638. Ivry SL, Knudsen GM, Caiazza F, Sharib JM, Jaradeh K, Ravalin M, O'Donoghue AJ, Kirkwood KS, Craik CS. PMID: 31256057.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. J Am Coll Surg. 2020 01; 230(1):53-63.e1. Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS. PMID: 31672679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Abdominal Imaging Does Not Detect Higher Rates of Pancreatic Cysts or Cyst-Associated Pancreatic Adenocarcinoma in BRCA Mutation Carriers. Journal of the American College of Surgeons. 2019 Oct 1; 229(4):s170. Jeremy Sharib, Carrie Cao, Paige Bracci, Amie Blanco, Dena Goldberg, Laura Esserman, Kimberly Kirkwood. .
      View in: Publisher Site   Mentions:
    7. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Nat Commun. 2019 07 11; 10(1):3055. Wang MT, Fer N, Galeas J, Collisson EA, Kim SE, Sharib J, McCormick F. PMID: 31296870.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    8. Sensitivity and Specificity Required for Diagnostics or Management Guidelines for Intraductal Papillary Mucinous Neoplasms to Be Cost-Effective. Journal of the American College of Surgeons. 2018 Oct 1; 227(4):s180-s181. Jeremy Sharib, Kenneth Wimmer, Annabelle L. Fonseca, Yu Shen, Eugene J. Koay, Anirban Maitra, Laura Esserman, Elissa Ozanne, Kimberly S. Kirkwood. .
      View in: Publisher Site   Mentions:
    9. Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making? Surgery. 2018 12; 164(6):1178-1184. Sharib JM, Fonseca AL, Swords DS, Jaradeh K, Bracci PM, Firpo MA, Hatcher S, Scaife CL, Wang H, Kim GE, Mulvihill SJ, Maitra A, Koay EJ, Kirkwood KS. PMID: 30170819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Which Clinical Features Predict Overtreatment for Intraductal Papillary Mucinous Neoplasms?. Journal of the American College of Surgeons. 2017 Oct 1; 225(4):s140. Jeremy Sharib, Annabelle L. Fonseca, Grace E. Kim, Eugene J. Koay, Anirban Maitra, Kimberly S. Kirkwood. .
      View in: Publisher Site   Mentions:
    11. Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts. Clin Cancer Res. 2017 Aug 15; 23(16):4865-4874. Ivry SL, Sharib JM, Dominguez DA, Roy N, Hatcher SE, Yip-Schneider MT, Schmidt CM, Brand RE, Park WG, Hebrok M, Kim GE, O'Donoghue AJ, Kirkwood KS, Craik CS. PMID: 28424202.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    12. Early and accurate diagnosis of pancreatic cancer? Oncotarget. 2016 12 27; 7(52):85676-85677. Sharib J, Kirkwood K. PMID: 27829239.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Three-dimensional Radiologic Assessment of Chemotherapy Response in Ewing Sarcoma Can Be Used to Predict Clinical Outcome. Radiology. 2016 09; 280(3):905-15. Aghighi M, Boe J, Rosenberg J, Von Eyben R, Gawande RS, Petit P, Sethi TK, Sharib J, Marina NM, DuBois SG, Daldrup-Link HE. PMID: 26982677.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    14. Comparison of Latino and non-Latino patients with Ewing sarcoma. Pediatr Blood Cancer. 2014 Feb; 61(2):233-7. Sharib J, Horvai A, Gray Hazard FK, Daldrup-Link H, Goldsby R, Marina N, DuBois SG. PMID: 23970433.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Panurethral stricture after photovaporization of the prostate for benign prostatic hyperplasia. J Endourol. 2012 May; 26(5):520-3. Sharib J, Truntzer J, Young J, Jordan G, Gelman J. PMID: 22201339.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer. 2012 Oct; 59(4):611-6. Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG. PMID: 22180320.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    17. Ixabepilone, mitoxantrone, and prednisone for metastatic castration-resistant prostate cancer after docetaxel-based therapy: a phase 2 study of the Department Of Defense Prostate Cancer Clinical Trials Consortium. Cancer. 2011 Jun 01; 117(11):2419-25. Harzstark AL, Rosenberg JE, Weinberg VK, Sharib J, Ryan CJ, Smith DC, Pagliaro LC, Beer TM, Liu G, Small EJ. PMID: 24048789.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    18. Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study. Urol Oncol. 2012 Jul-Aug; 30(4):408-14. Friedlander TW, Weinberg VK, Small EJ, Sharib J, Harzstark AL, Lin AM, Fong L, Ryan CJ. PMID: 20884247.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    19. Phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy: a study of the department of defense prostate cancer clinical trials consortium. J Clin Oncol. 2009 Jun 10; 27(17):2772-8. Rosenberg JE, Ryan CJ, Weinberg VK, Smith DC, Hussain M, Beer TM, Ryan CW, Mathew P, Pagliaro LC, Harzstark AL, Sharib J, Small EJ. PMID: 19349545.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    20. Second-line combination chemotherapy: A phase I study of ixabepilone, mitoxantrone, and prednisone in patients with metastatic hormone-refractory prostate cancer (HRPC) refractory to docetaxel-based therapy. Journal of Clinical Oncology. 2008 May 20; 26(15_suppl):5151-5151. A. L. Harzstark, V. K. Weinberg, J. Sharib, D. C. Smith, M. H. Hussain, T. M. Beer, C. W. Ryan, P. Mathew, C. J. Ryan, E. J. Small, J. E. Rosenberg. .
      View in: Publisher Site   Mentions:
    Jeremy's Networks
    Concepts (111)
    Derived automatically from this person's publications.
    _
    Co-Authors (28)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _